Claix, France

Marc Flippe

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Marc Flippe

Introduction

Marc Flippe is a notable inventor based in Claix, France. He has made significant contributions to the field of drug delivery devices, holding a total of four patents. His work focuses on creating innovative adaptors that enhance the functionality and efficiency of these medical devices.

Latest Patents

One of Marc Flippe's latest patents is an adaptor for connecting a connector to a drug delivery device. This adaptor features a globally tubular body with a proximal region equipped with an engagement element for mounting on the drug delivery device. The distal region includes an internal thread designed to cooperate with an external thread of the connector, allowing for a secure connection. Additionally, the internal thread crest is designed with a deformable radial end part that can be radially deformed when the connector is screwed into the adaptor. Another patent involves an adaptor for a drug delivery device that has a reservoir and a longitudinal tip. This adaptor creates an annular space that can accommodate an adhesive layer, bonding the adaptor to the longitudinal tip of the device.

Career Highlights

Marc Flippe works at Becton Dickinson France, a company known for its innovative medical technologies. His role involves developing advanced solutions for drug delivery systems, contributing to the improvement of patient care through better medical devices.

Collaborations

Marc collaborates with talented individuals such as Freddy Mills and Lionel Maritan. Their combined expertise fosters a creative environment that leads to groundbreaking innovations in the medical field.

Conclusion

Marc Flippe's work exemplifies the spirit of innovation in the medical device industry. His patents reflect a commitment to enhancing drug delivery systems, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…